Literature DB >> 17333498

Common problems with antiretroviral therapy among three Swedish groups of HIV infected individuals.

Amadou Jallow1, Sofia Kälvemark Sporrong, Lilian Walther-Jallow, Peter M Persson, Urban Hellgren, Orjan Ericsson.   

Abstract

OBJECTIVE: The main objective of this study was to identify and compare the common problems and difficulties associated with combination antiretroviral therapy (CART) as experienced by three major groups of HIV infected individuals (homo- or bisexuals, former injecting drug users and origins of Sub-Saharan Africa) in Sweden.
METHODS: Based on the results from in-depth interviews with 15 representatives from the three major groups, a questionnaire was designed for use in a problem detection study (PDS). The study was conducted with 195 HIV-positive patients residing in the major cities of Sweden.
RESULTS: The overall response rate was 79%. The problems identified in all three groups were negative attitudes from the public, worries about disease progression or therapy failure, medication or drug-related problems and problems in connection to pharmacy visits. A specific problem in the homo- or bisexual group was drug-related problems such as adverse effects, drug interactions and pill burden. For former injecting drug users, the specific problem was disease-related conflicts with relatives and the problem of coping with the social and psychological burden caused by the HIV infection. The African group termed the risk of exposing their medication at the pharmacy as a specific problem, as this could reveal their HIV status.
CONCLUSIONS: Our findings regarding problems with CART in three patient groups in Sweden may be of use to tailor pharmacy care to HIV infected individuals. General strategies to improve adherence need to be complemented with approaches that will address the specific needs for the different patient groups affected by HIV. Further studies on group-specific interventions that promote concordance and adherence to CART will be necessary to minimize therapy failure and viral resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333498     DOI: 10.1007/s11096-007-9092-4

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  28 in total

Review 1.  Fat distribution and metabolic changes in patients with HIV infection.

Authors:  S Safrin; C Grunfeld
Journal:  AIDS       Date:  1999-12-24       Impact factor: 4.177

2.  Adherence and antiretroviral therapy in injection drug users.

Authors:  R Sherer
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

3.  [Adherence to very active antiretroviral treatment: impact of individualized assessment].

Authors:  H Knobel; A Carmona; J L López; J L Gimeno; P Saballs; A González; A Guelar; A Díez
Journal:  Enferm Infecc Microbiol Clin       Date:  1999-02       Impact factor: 1.731

4.  Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice.

Authors:  Laura Romano; Giulietta Venturi; Saverio Giomi; Luigi Pippi; Pier E Valensin; Maurizio Zazzi
Journal:  J Med Virol       Date:  2002-02       Impact factor: 2.327

5.  Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

Authors:  P T Nieuwkerk; M A Sprangers; D M Burger; R M Hoetelmans; P W Hugen; S A Danner; M E van Der Ende; M M Schneider; G Schrey; P L Meenhorst; H G Sprenger; R H Kauffmann; M Jambroes; M A Chesney; F de Wolf; J M Lange
Journal:  Arch Intern Med       Date:  2001-09-10

6.  Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study.

Authors:  C A Kleeberger; J P Phair; S A Strathdee; R Detels; L Kingsley; L P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

7.  The patient's perspective on life with antiretroviral treatment: results of an 887-person survey.

Authors:  D R Bertholon; H Rossert; S Korsia
Journal:  AIDS Read       Date:  1999-10

8.  Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study.

Authors:  A Mocroft; R Brettle; O Kirk; A Blaxhult; J M Parkin; F Antunes; P Francioli; A D'Arminio Monforte; Z Fox; J D Lundgren
Journal:  AIDS       Date:  2002-08-16       Impact factor: 4.177

9.  Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population.

Authors:  Søren Jensen-Fangel; Lars Pedersen; Court Pedersen; Carsten S Larsen; Palle Tauris; Axel Møller; Henrik T Sørensen; Niels Obel
Journal:  AIDS       Date:  2004-01-02       Impact factor: 4.177

10.  Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort.

Authors:  Megan E O'Brien; Rebecca A Clark; C Lynn Besch; Leann Myers; Patricia Kissinger
Journal:  J Acquir Immune Defic Syndr       Date:  2003-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.